Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.
第一作者:
Eric G,Vajda
第一单位:
Discovery Research, Ligand Pharmaceuticals, San Diego, California 92121, USA. evajda@ligand.com
作者:
医学主题词
吸收测定法, 光子(Absorptiometry, Photon);雄激素拮抗药(Androgen Antagonists);动物(Animals);体重(Body Weight);骨密度(Bone Density);骨疾病, 代谢性(Bone Diseases, Metabolic);二膦酸盐类(Diphosphonates);药物协同作用(Drug Synergism);药物疗法, 联合(Drug Therapy, Combination);雌激素类(Estrogens);女(雌)性(Female);股骨(Femur);腰椎(Lumbar Vertebrae);男(雄)性(Male);睾丸切除术(Orchiectomy);器官测量(Organ Size);骨钙素(Osteocalcin);卵巢切除术(Ovariectomy);吡咯类(Pyrroles);喹诺酮类(Quinolones);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);转录, 遗传(Transcription, Genetic)
DOI
10.1359/jbmr.081007
PMID
18847323
发布时间
2019-01-10
- 浏览48
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



